317 related articles for article (PubMed ID: 28424852)
21. Application of recombinant BMP-7 on persistent upper and lower limb non-unions.
Dimitriou R; Dahabreh Z; Katsoulis E; Matthews SJ; Branfoot T; Giannoudis PV
Injury; 2005 Nov; 36 Suppl 4():S51-9. PubMed ID: 16291324
[TBL] [Abstract][Full Text] [Related]
22. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives.
Schmidmaier G; Schwabe P; Wildemann B; Haas NP
Injury; 2007 Sep; 38 Suppl 4():S35-41. PubMed ID: 18224735
[TBL] [Abstract][Full Text] [Related]
23. BMPs: Options, indications, and effectiveness.
Giannoudis PV; Dinopoulos HT
J Orthop Trauma; 2010 Mar; 24 Suppl 1():S9-16. PubMed ID: 20182245
[TBL] [Abstract][Full Text] [Related]
24. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
[TBL] [Abstract][Full Text] [Related]
25. Clinical applications of growth factors in bone injuries: experience with BMPs.
Ronga M; Fagetti A; Canton G; Paiusco E; Surace MF; Cherubino P
Injury; 2013 Jan; 44 Suppl 1():S34-9. PubMed ID: 23351868
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic proteins in fracture repair.
Dumic-Cule I; Peric M; Kucko L; Grgurevic L; Pecina M; Vukicevic S
Int Orthop; 2018 Nov; 42(11):2619-2626. PubMed ID: 30219967
[TBL] [Abstract][Full Text] [Related]
27. [Bone morphogenetic proteins in the skeletal system].
Bramlage CP; Häupl T; Kaps C; Bramlage P; Müller GA; Strutz F
Z Rheumatol; 2005 Sep; 64(6):416-22. PubMed ID: 16184350
[TBL] [Abstract][Full Text] [Related]
28. Neoplasia following use of BMPs: is there an increased risk?
Pountos I; Panteli M; Georgouli T; Giannoudis PV
Expert Opin Drug Saf; 2014 Nov; 13(11):1525-34. PubMed ID: 25283875
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenic protein and its application in trauma cases: a current concept update.
Vaibhav B; Nilesh P; Vikram S; Anshul C
Injury; 2007 Nov; 38(11):1227-35. PubMed ID: 17307180
[TBL] [Abstract][Full Text] [Related]
30. Autograft versus BMPs for the treatment of non-unions: what is the evidence?
Blokhuis TJ; Calori GM; Schmidmaier G
Injury; 2013 Jan; 44 Suppl 1():S40-2. PubMed ID: 23351869
[TBL] [Abstract][Full Text] [Related]
31. Treatment of allograft nonunions with recombinant human bone morphogenetic proteins (rhBMP).
Delloye C; Suratwala SJ; Cornu O; Lee FY
Acta Orthop Belg; 2004 Dec; 70(6):591-7. PubMed ID: 15669462
[TBL] [Abstract][Full Text] [Related]
32. Role of Recombinant Human Bone Morphogenetic Protein-2 on Hindfoot Arthrodesis.
Hreha J; Krell ES; Bibbo C
Foot Ankle Clin; 2016 Dec; 21(4):793-802. PubMed ID: 27871412
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions.
Kloen P; Lauzier D; Hamdy RC
Bone; 2012 Jul; 51(1):59-68. PubMed ID: 22521262
[TBL] [Abstract][Full Text] [Related]
34. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience.
Kanakaris NK; Calori GM; Verdonk R; Burssens P; De Biase P; Capanna R; Vangosa LB; Cherubino P; Baldo F; Ristiniemi J; Kontakis G; Giannoudis PV
Injury; 2008 Sep; 39 Suppl 2():S83-90. PubMed ID: 18804578
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human bone morphogenetic protein 2 enhances bone healing in an experimental model of fractures at risk of non-union.
Eckardt H; Christensen KS; Lind M; Hansen ES; Hall DW; Hvid I
Injury; 2005 Apr; 36(4):489-94. PubMed ID: 15755429
[TBL] [Abstract][Full Text] [Related]
36. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion.
White AP; Vaccaro AR; Hall JA; Whang PG; Friel BC; McKee MD
Int Orthop; 2007 Dec; 31(6):735-41. PubMed ID: 17962946
[TBL] [Abstract][Full Text] [Related]
37. Clinical applications of bone morphogenetic proteins: current evidence.
Kanakaris NK; Giannoudis PV
J Surg Orthop Adv; 2008; 17(3):133-46. PubMed ID: 18851797
[TBL] [Abstract][Full Text] [Related]
38. Bone Morphogenetic Protein for the Healing of Tibial Fracture: A Meta-Analysis of Randomized Controlled Trials.
Dai J; Li L; Jiang C; Wang C; Chen H; Chai Y
PLoS One; 2015; 10(10):e0141670. PubMed ID: 26509264
[TBL] [Abstract][Full Text] [Related]
39. The Use of Growth Factors and Mesenchymal Stem Cells in Orthopaedics: In particular, their use in Fractures and Non-Unions: A Systematic Review.
Sinclair KL; Mafi P; Mafi R; Khan WS
Curr Stem Cell Res Ther; 2017; 12(4):312-325. PubMed ID: 27306399
[TBL] [Abstract][Full Text] [Related]
40. Complications associated with the use of bone morphogenetic protein in pediatric patients.
Oetgen ME; Richards BS
J Pediatr Orthop; 2010 Mar; 30(2):192-8. PubMed ID: 20179569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
